Transfer of Maternal Immunity to Newborns of Diabetic Mothers

Table 1

Mean (±SD) glucose level, leukocyte count, and viability in colostrum, maternal blood, and cord blood from normoglycemic and hyperglycemic women.

Parameter	Sample	Normoglycemic	Hyperglycemic	Statistical contrast
Glucose level (mg/dL)	Colostrum	76 ± 18.0	148.1 ± 31.8^†	Colostrum versus blood 𝐹=1.77; 𝑃=0.57
	Maternal blood	80.95 ± 9.24	111.3 ± 12.7^†	Normo- versus hyperglycemic 𝐹=19.2; 𝑃=0.007
	Cord blood	75.3 ± 10.5	95.7 ± 5.7^†
Mononuclear phagocytes count (×10^6 cell/mL)	Colostrum	4.7 ± 0.4	4.5 ± 0.7	Colostrum versus blood 𝐹=6.5; 𝑃=0.04
	Maternal blood	5.3 ± 0.7	5.1 ± 0.5	Normo- versus hyperglycemic 𝐹=2.18; 𝑃=0.23
	Cord blood	3.5 ± 0.9*	3.2 ± 1.1*
Mononuclear phagocytes viability (%)	Colostrum	94 ± 4.5	93 ± 4.2	Colostrum versus blood 𝐹=1.85; 𝑃=0.71
	Maternal blood	95 ± 5.4	93 ± 4.3	Normo- versus hyperglycemic 𝐹=0.8424; 𝑃=0.9160
	Cord blood	95 ± 3.4	90 ± 5.7

∗Statistical differences between leukocyte count in cord blood and leukocyte count in maternal blood and colostrum (within a column). †Statistical differences in glucose levels between normoglycemic and hyperglycemic women (in a row).